
Biora Therapeutics Inc
NASDAQ:BIOR


to continue BIOR research
to continue BIOR research
You've reached your weekly stock limit.
Sign UpBiora Therapeutics Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.22
7.57
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Biora Therapeutics Inc hold over its rivals?
What risks and challenges
does Biora Therapeutics Inc face in the near future?
Provide an overview of the primary business activities
of Biora Therapeutics Inc.
Show me price targets
for Biora Therapeutics Inc made by professional analysts.
Provide an overview of the primary business activities
of Biora Therapeutics Inc.
What unique competitive advantages
does Biora Therapeutics Inc hold over its rivals?
What risks and challenges
does Biora Therapeutics Inc face in the near future?
Has there been any significant insider trading activity
in Biora Therapeutics Inc recently?
Summarize the latest earnings call
of Biora Therapeutics Inc.
Show all valuation multiples
for Biora Therapeutics Inc.
Provide P/S
for Biora Therapeutics Inc.
Provide P/E
for Biora Therapeutics Inc.
Provide P/OCF
for Biora Therapeutics Inc.
Provide P/FCFE
for Biora Therapeutics Inc.
Provide P/B
for Biora Therapeutics Inc.
Provide EV/S
for Biora Therapeutics Inc.
Provide EV/GP
for Biora Therapeutics Inc.
Provide EV/EBITDA
for Biora Therapeutics Inc.
Provide EV/EBIT
for Biora Therapeutics Inc.
Provide EV/OCF
for Biora Therapeutics Inc.
Provide EV/FCFF
for Biora Therapeutics Inc.
Provide EV/IC
for Biora Therapeutics Inc.
Show me price targets
for Biora Therapeutics Inc made by professional analysts.
What are the Revenue projections
for Biora Therapeutics Inc?
How accurate were the past Revenue estimates
for Biora Therapeutics Inc?
What are the Net Income projections
for Biora Therapeutics Inc?
How accurate were the past Net Income estimates
for Biora Therapeutics Inc?
What are the EPS projections
for Biora Therapeutics Inc?
How accurate were the past EPS estimates
for Biora Therapeutics Inc?
What are the EBIT projections
for Biora Therapeutics Inc?
How accurate were the past EBIT estimates
for Biora Therapeutics Inc?
Compare the revenue forecasts
for Biora Therapeutics Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Biora Therapeutics Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Biora Therapeutics Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Biora Therapeutics Inc compared to its peers.
Compare the P/E ratios
of Biora Therapeutics Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Biora Therapeutics Inc with its peers.
Analyze the financial leverage
of Biora Therapeutics Inc compared to its main competitors.
Show all profitability ratios
for Biora Therapeutics Inc.
Provide ROE
for Biora Therapeutics Inc.
Provide ROA
for Biora Therapeutics Inc.
Provide ROIC
for Biora Therapeutics Inc.
Provide ROCE
for Biora Therapeutics Inc.
Provide Gross Margin
for Biora Therapeutics Inc.
Provide Operating Margin
for Biora Therapeutics Inc.
Provide Net Margin
for Biora Therapeutics Inc.
Provide FCF Margin
for Biora Therapeutics Inc.
Show all solvency ratios
for Biora Therapeutics Inc.
Provide D/E Ratio
for Biora Therapeutics Inc.
Provide D/A Ratio
for Biora Therapeutics Inc.
Provide Interest Coverage Ratio
for Biora Therapeutics Inc.
Provide Altman Z-Score Ratio
for Biora Therapeutics Inc.
Provide Quick Ratio
for Biora Therapeutics Inc.
Provide Current Ratio
for Biora Therapeutics Inc.
Provide Cash Ratio
for Biora Therapeutics Inc.
What is the historical Revenue growth
over the last 5 years for Biora Therapeutics Inc?
What is the historical Net Income growth
over the last 5 years for Biora Therapeutics Inc?
What is the current Free Cash Flow
of Biora Therapeutics Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Biora Therapeutics Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Biora Therapeutics Inc
NASDAQ:BIOR
|
994.4k USD | -0 | |
US |
C
|
Cigna Group
XMUN:CGN
|
73.8B EUR | 8.4 |
|
US |
![]() |
Cigna Corp
NYSE:CI
|
85.3B USD | 8.4 |
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
83.8B USD | 13 |
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
27.8B EUR | 11.9 |
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
23.8B EUR | 10.3 |
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 15 |
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
20B USD | 13 |
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.9B EUR | 7.3 |
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
10.8B USD | 7.5 |
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
9.3B USD | 64.8 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Biora Therapeutics Inc
NASDAQ:BIOR
|
Average EV/EBITDA:
16
|
N/A | N/A | |
US |
C
|
Cigna Group
XMUN:CGN
|
8.4
|
4%
|
2.1 |
|
US |
![]() |
Cigna Corp
NYSE:CI
|
8.4
|
4%
|
2.1 |
|
US |
![]() |
CVS Health Corp
NYSE:CVS
|
13
|
25%
|
0.5 |
|
DE |
![]() |
Fresenius Medical Care AG
XMUN:FME
|
11.9
|
11%
|
1.1 |
|
DE |
![]() |
Fresenius SE & Co KGaA
XETRA:FRE
|
10.3
|
13%
|
0.8 |
|
US |
![]() |
Laboratory Corporation of America Holdings
NYSE:LH
|
15
|
16%
|
0.9 |
|
US |
![]() |
Quest Diagnostics Inc
NYSE:DGX
|
13
|
8%
|
1.6 |
|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
7.3
|
11%
|
0.7 |
|
US |
![]() |
DaVita Inc
NYSE:DVA
|
7.5
|
4%
|
1.9 |
|
US |
![]() |
Hims & Hers Health Inc
NYSE:HIMS
|
64.8
|
86%
|
0.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.